💻 Technology 6h ago · Kate Park

Intero Biosystems wants drugmakers to test on mini human intestines, not animals

TechCrunch
TechCrunch startup news
View Channel →
Source ↗ 👁 2 💬 0
Intero Biosystems is selling lab-grown human intestines to drugmakers as regulators push for alternatives to animal testing, while the startup looks to scale production and expand its organoid technology.

Comments (0)

Sign in to join the discussion

More Like This

📰
Exclusive: British Business Bank puts £180m into six AI funds, including Evantic and EF
Sifted · 49m ago
📰
EU Inc campaigners accuse lawmakers of ‘killing’ landmark reforms
Sifted · 49m ago
📰
What Europe’s spinouts need to capitalise on deeptech boom: patient capital, customer obsession and support for female founders
Sifted · 49m ago
📰
AI personal finance platform Matters raises $5m pre-seed
Sifted · 49m ago
📰
Tandem Health tops Sifted’s ranking of 100 standout AI startups in Europe
Sifted · 50m ago
ScaleFlux bets its controller chips can break AI’s memory bottleneck
SiliconANGLE · 2h ago